What is the role of medications in the treatment of sitosterolemia (phytosterolemia)?

Updated: May 24, 2019
  • Author: Robert D Steiner, MD; Chief Editor: Luis O Rohena, MD, MS, FAAP, FACMG  more...
  • Print

The goals of pharmacotherapy are to reduce morbidity and prevent complications. Ezetimibe improves VLDL and HDL subfraction distribution, thereby reducing the atherogenic lipid profile, thus providing potential clinical benefit in sitosterolemia even beyond cholesterol and plant sterol reduction. [31]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!